Abstract
The liver plays a key role during fasting to maintain energy homeostasis and euglycemia via metabolic processes mainly orchestrated by the insulin/glucagon ratio. We report here that fasting or calorie restriction protocols in C57BL6 mice promote a marked decrease in the hepatic protein levels of G protein-coupled receptor kinase 2 (GRK2), an important negative modulator of both G protein-coupled receptors (GPCRs) and insulin signaling. Such downregulation of GRK2 levels is liver-specific and can be rapidly reversed by refeeding. We find that autophagy, and not the proteasome, represents the main mechanism implicated in fasting-induced GRK2 degradation in the liver in vivo. Reducing GRK2 levels in murine primary hepatocytes facilitates glucagon-induced glucose production and enhances the expression of the key gluconeogenic enzyme Pck1. Conversely, preventing full downregulation of hepatic GRK2 during fasting using adenovirus-driven overexpression of this kinase in the liver leads to glycogen accumulation, decreased glycemia, and hampered glucagon-induced gluconeogenesis, thus preventing a proper and complete adaptation to nutrient deprivation. Overall, our data indicate that physiological fasting-induced downregulation of GRK2 in the liver is key for allowing complete glucagon-mediated responses and efficient metabolic adaptation to fasting in vivo.
Original language | American English |
---|---|
Pages (from-to) | 399-409 |
Number of pages | 11 |
Journal | FASEB Journal |
Volume | 34 |
Issue number | 1 |
DOIs | |
State | Published - 1 Jan 2020 |
Externally published | Yes |
Bibliographical note
Funding Information:We acknowledge support by Ministerio de Economía y Competitividad (MINECO/FEDER), Spain (grant SAF2017‐84125‐R to F.M. and C. M.); CIBER de Enfermedades Cardiovasculares (CIBERCV). Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to FM, co‐funded with European FEDER contribution); European Foundation for the Study of Diabetes (EFSD) Novo Nordisk Partnership for Diabetes Research in Europe Grant (to FM); NIH R01 DK089883 grant to P.P. and Programa de Actividades en Biomedicina de la Comunidad de Madrid‐B2017/BMD‐3671‐INFLAMUNE to F.M. We appreciate the help of the CBMSO Facilities, in particular Genomics and Animal Care. K.S. is funded by the Charles King Postdoctoral Fellowship. We also acknowledge the support of Contratos Predoctorales para Formación de Personal Investigador 2017 (FPI‐UAM) from Universidad Autónoma de Madrid to A. C. A. and institutional support to the CBMSO from Fundación Ramón Areces and Fundación Banco de Santander.
Funding Information:
We acknowledge support by Ministerio de Economía y Competitividad (MINECO/FEDER), Spain (grant SAF2017-84125-R to F.M. and C. M.); CIBER de Enfermedades Cardiovasculares (CIBERCV). Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to FM, co-funded with European FEDER contribution); European Foundation for the Study of Diabetes (EFSD) Novo Nordisk Partnership for Diabetes Research in Europe Grant (to FM); NIH R01 DK089883 grant to P.P. and Programa de Actividades en Biomedicina de la Comunidad de Madrid-B2017/BMD-3671-INFLAMUNE to F.M. We appreciate the help of the CBMSO Facilities, in particular Genomics and Animal Care. K.S. is funded by the Charles King Postdoctoral Fellowship. We also acknowledge the support of Contratos Predoctorales para Formación de Personal Investigador 2017 (FPI-UAM) from Universidad Autónoma de Madrid to A. C. A. and institutional support to the CBMSO from Fundación Ramón Areces and Fundación Banco de Santander.
Publisher Copyright:
© 2019 Federation of American Societies for Experimental Biology
Keywords
- GPCR
- GRK2
- autophagy
- calorie restriction
- fasting
- glucagon signaling
- gluconeogenesis
- intermittent fasting